News

December 4, 2020
ATLANTA, December 4, 2020 —Treatment of SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses virus transmission within 24 hours, researchers in the Institute for Biomedical Sciences at Georgia…
November 20, 2020
Lightning 12 and Separator 12 Now Indicated for Treatment of PE
November 19, 2020
Buenos Aires, Argentina, November 19, 2020:  Lockdown due to the COVID-19 pandemic is associated with an increase in high blood pressure among patients admit
November 19, 2020
Research may lead to identifying novel therapies for cardiac patients
November 19, 2020
- RAPID and completed NODE-301 studies could potentially fulfill efficacy requirement for future NDA for etripamil in patients with PSVT – - RAPID investigates efficacy of second dose of etripamil for patients with persistent PSVT – - RAPID…
November 18, 2020
November 18, 2020 — Deep vein blockages impact more than 27 million people worldwide. For years, many people suffering from venous disease didn’t have access to advanced treatment options.
November 18, 2020
Only program in New York City to receive prestigious recognition 
November 17, 2020
Arlington, VA (November 17, 2020) — The Society of Cardiovascular Computed Tomography (SCCT), in collaboration with the North American Society of Cardiovascular Imaging (NASCI), has released a new 
November 17, 2020
This cutting-edge technology supports Burlington’s made-to-measure capabilities without the need